14UNAIDS HIV 39% i 9 ii9iii UNAIDS x.9x.9x1= ?? UNAIDS % 77%8% 44.7x.77x.8x1=

DeCEMBER, 17 No.34 HIV 169-73 1-1-1-13TEL 3-5937-4413:3 19:3 FAX 3-5937-443E-mail info@janpplus.jp http://janpplus.jp/!9-9-9!... 1-3 POSITIVE HIV/AIDS UNAIDS!... 4-5 JaNP+HIV Cafe Bar an opportunity...

A B A E

10533-68-3955 10533-68-3955 10533-68-3804 RP A-6 10533-68-3804 10533-69-9615 10533-57-2161 B-2 10533-68-2274 10533-68-2221 10533-67-6282 A-6 10533-57-2161 E-3 10533-68-5161 10533-68-3553 D-2 D-2 10533-69-5258

‚æ01Łª“û†œ070203/1‘Í

131314 131314 100 16712 1 1 16624 63 4 89 27 3 2 2 1 8 38418 23203 132 252710129 134 24 30201320 136 30 144 30146-18239 23 2 132144 132 64 1322132113261 13413412 1348134212 134622 63013626 1441330 3 11520

スライド タイトルなし

C/NC : committed/noncommitted

C/NC : committed/noncommitted 110 time post-icd implant 1) The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report : Effect of encainaide and flecainide on mortality in a

GJG160842_O.QXD

要望番号 ;Ⅱ-183 未承認薬 適応外薬の要望 ( 別添様式 ) 1. 要望内容に関連する事項 要望者学会 ( 該当する ( 学会名 ; 日本感染症学会 ) ものにチェックする ) 患者団体 ( 患者団体名 ; ) 個人 ( 氏名 ; ) 優先順位 1 位 ( 全 8 要望中 ) 要望する医薬品

未承認薬 適応外薬の要望 ( 別添様式 ) 1. 要望内容に関連する事項 要望者学会 ( 該当する ( 学会名 ; 日本感染症学会 ) ものにチェックする ) 患者団体 ( 患者団体名 ; ) 個人 ( 氏名 ; ) 優先順位 1 位 ( 全 8 要望中 ) 要望する医薬品 要望内容 成分名 ( 一般名 ) 販売名 会社名 国内関連学会 未承認薬 適応 外薬の分類 ( 該当するものにチェックする )

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書（案）

VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.

Rinku General Medical Center

Rinku General Medical Center 4860 100 1620 Ann Intern Med. 1966; 64: 328 40 CHOP 63 1 83 J Clin Oncol. 1998; 16: 20065-69 Febrile Neutropenia IDSA(Infectious Diseases Society of America) 2002 Guidelines

腎不全-第22回.indd

untitled

HBV HBV (1964) HDV (1977) HCV (1988) 2009 Yotsuyanagi H et al. J Med Virol 2005 Yotsuyanagi H et al. J Hepatol 2002 Universal vaccination (UV) 45 HB 2009 1/3 Progress Toward the Elimination

核融合…予稿集

9:30 9:45 9:45 10:00 10:05 10:10 10:10 10:40 2 3 10:40 11:10 11:10 11:40 11:40 12:00 6 7 8 9 10 11 13:10 13:20 13:20 14:00 14:00 14:20 14:20 14:40 14:50 15:20 15:20 15:50 15:50 15:55 14 15 16 17 18 19

2009 Aida et al. Caries Res 2006;40 2000 100 % 78.7 88.0 96.6 98.8 98.8 98.8 100.0 100.0 100 75 69.4 50 75.3 74.8 73.3 73.1 73.0 72.4 71.8 71.7 51.7 40.2 69.4 68.8 73.6 25 22.3 32.8 21.9 22.9 22.1

MM0508-見聞記01.ind

多目的な障害予防のための「ニコニコ体操」

"Enjoyable Exercises" as multipurpose prevention exercise Koji Yamashita1) Department of Physical Therapy, Faculty of Health Sciences, Aomori University of Health and Welfare 13)Marras WS, Ferguson

1 見出し1，12ポ，日本語ゴシック，英語Arial，段落後は6ポの設定です

8. Page1 8. B 1 5) 6) 2099 2370 50 400 mg 19 (1) 1) (a) 78.9% 30/38 4 3 35.7% 5/14 71.4% 10/1485.7% 12/142 1 83.3% 5/63 2 1 1 1 8. Page2 (b) 2099 1897 82.4% 1562/1897 2 84.0% 1298/1545 3 2 80.4% 472/58779.0%

24 RS 24 RSRespiratory Syncytial Virus RS BPD24 24CHD RS RS BPD CHD

Immunocompromised Children 24 RS24 24 RS 24 RSRespiratory Syncytial Virus RS 28 12 29 35 6 6BPD24 24CHD 24 24 1 RS 28 2935 12 6 RS BPD 246 1 1 CHD 24 24 24 2 RS [1] [1.1] RS 24 RS T DiGeorge Wiskott- Aldrich

28 1 1a 1b 2 MRI T2 3 CT C3 N95 N95 6ml 90

2015 28 1 89 93 CT C3 Tb PCR XP WBC 7 600/mm 3 CRP 4 08mg/dl MRI MRI CT MRI WBC 9 700/mm 3 CRP 6 09mg/dl CT C3 C2 C7 low density area CT 89 28 1 1a 1b 2 MRI T2 3 CT C3 N95 N95 6ml 90 28 1 4 CT C2 C7 low

産衛誌57-4たより.indb

A89 26 7 1 9 4 33 1 87 A90 24 A91 23 ACOH2014 A92 4 1 2 3 4 5 6 7 A93 A94 A95 A96 A97 A98 A99 A100 A101 27 8 1 9 A102 4 33 A103 A104 26 3 140 27 1 A105 27 A106 A107 A108 A109 A110 A111 A112 A113 et al

untitled

2005 10 13 Dr. RGA 19602000 10 Australian Institute of of Health and and Welfare 2004 ABS Cat. Cat. No. No. 3201.0; AIHW National Population Database 1875 2 211997 8 122164 http://www.wowzone.com/calment.htm

442号

untitled

x [1] Palmer Jeffrey, B. and M. Hiiemae Karen, (propulsion). (1343-8441), 1997. 1(1): p. 15-30. [2] Saitoh, E., et al., Chewing and food consistency: effects on bolus transport and swallow initiation.

Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood

Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood Fig.1 Distribution of the cases with bacterial meningitis by age and pathogens Chiba

胆石症

,. vs 64 .. vs. -, Ransohoff DF, Gracie W. Treatment of gallstones. Ann Intern Med ; 119 : - Halldestam I, Enell EL, Kullman E, et al. Development of symptoms and complications in individuals with asymptomatic

37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate

37, 9-14, 2017 : 36 2015 8 6 cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin 20 1983 2016 3 CD 7 Clostridium difficile CD CD associated diarrhea : CDAD CD 1,2 PPI 3 1 36 33 2015 8 6 5 5

がん患者の終末期ケアにおける通所リハビリテーションの役割　介護保険によるがん終末期ケアの可能性

2 3 3 6 7 49 53 13 61 22 27 65 68 34 47 71 73 4 5 7 6 8 9 10 11 12 13 14 15 44 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4

Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents

D 012 Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents DATA : 1 DATA : 2 3 DATA : UNGITEC 1 1 DATA : 20pg/mL 1020pg/mL 10pg/mL (cut off 20pg/mL) 90.2%(37/41) 100%(85/85) 96.8%(122/126)

E Societe de Pathologie Infectieuse de Langue Francaise (, 1991) E Spanish Thoracic Society (1992) E American Thoracic Society (ATS : 1993. ü ù2001 ) E British Thoracic Society (1993, ü è2001 ) E Canadian

- 1 -

- 1 - HIV cmc cmc - 2 - cmc() ( ) 5-3 - - 4 - (1) (2) (3) ( ) - 5 - 0537-73-2662 0537-35-2971 0548-63-1251 9 00 16 00-6 - - 7 - 2 3 4 5 6 1,328 1,848 2,368 2,888 3,408-8 - - 9 - - 10 - - 11 - 3-12 - (

橡

TP T-13i AST ALT ALP Y CTP LOH CHE CRP 8.7 id 0.4 mg/d 21 AWL 131U/L 257 LU/L 12 111/L 234 11J/L 344 IU/L 0.30 mid No K a BUN ORE UA 142 meq/1 4.3 meqa 108 meqa 15.8 met! 0.71 mg/di 5.0 mg/d CEA 5_5 n8/m1

Microsoft PowerPoint - masayukiakiyama_20141103.pptx

untitled

26 9 201491 PL PL PL 1 1 2 3 4 1 1 2 3 4 1,000 10 501003 7 5 6 2 10 1 1 10 2 2 1,000 1,000 50100 50100 50100 50 100 5 6 3 4 3 2 1 10 1100 11,000 1 5001,000 150 1,000 1,000 1,000 90 15001,000 15,000 15,000

金融力調査

2 0 1 2 9 2 1 1 2 8 3 1 3 4 5 10,000 3,531 35.3% 419 164 39.1% 761 311 40.9% 3,279 948 28.9% 440 212 48.2% 1,399 524 37.5% 1,641 530 32.3% 598 247 41.3% 321 114 35.5% 1,142 481 42.1% 3,531 2,939 592 0332791111

untitled

CPF 30 65 23 7000 79 5900 3.5 1 Central Provident Fund CPF CPF CPF 55 CPF 1 2 CPF 3 CPF CPF 4 CPF 5 CPF CPF CPF Teo Besey Lai Si, Tsui-Auch 1 1. 3 2. (CPF) 5 CPF 3. CPF 9 CPF 4. CPF 1 1: CPF 2: CPF CPF

b n m, m m, b n 3

13th Annual Worlds of Flavor International Conference & Festival z x c v z x c v 2 b n m, m m, b n 3 . 0 1 2 3 4 5. 0 1 2 3 4 4 5 6 7 8 6 7 8 5 9 0 1 2 3 9 0 1 2 3 6 4 5 6 7 8 4 5 6 7 8 9 7 0 1 2 3 9 0

437“ƒ

et al., et al., et al., et al., et al., et al., 2 et al., et al., et al., Lancet Pharmacol Res. et al. Jpn J Cancer Res. et al. Jpn J Cancer Res. et al. Tohoku J Exp Med. et al. Jpn Circ J. et al. Cancer

1) Delbet P: Retrocissement du choledoque. Cholecysto-duodenostomie. Bull Mem Soc Nat Chir 50: 1144-1146, 1924 2) Wiesner RH, LaRusso NF: Clinicopathologic Features of the Syndrome of Primary Sclerosing

スライド 1

19 9 9 26 39 38 100 300 30 37 1 2 3 4 5 6 7 2004 Vol.132(12) Web http://www.nsknet.or.jp/katoh/honbun.html http://www.hyo-med.ac.jp/department/ped/qa/rota.html http://kodomo-qq.jp/ http://www.guide.metro.tokyo.jp/

_’£”R‡Ù‡©

29 31 38 2008 31 1) 2) 2) 3) 2) 1) 2008 302008 12 Activities of Daily Living ADL ADL 42 ADL ADL 1990 QOL Quality of Life QOL 1 QOL // 2 Activity of Daily Living ADL Performance Status PS ADL 3 1) 2) 3)

01 BSNET2016 program 1606030

The Empirical Study on New Product Concept of the Dish Washer Abstract

The Empirical Study on New Product Concept of the Dish Washer Abstract t t Cluster Analysis For Applications International Conference on Quality 96 in Yokohama Clustering Algorithms

Microsoft Word - TOH38_Acquired_Hemophilia final.doc

Mauricio Silva James V. Luck Jr. International Hemophilia Training Center at Orthopaedic Hospital David Geffen School of Medicine California, United States Adolfo Llinás Hemophilia Treatment Center Fundación

CALL 1 e-learning CALL International Conference on Development of Dry Lands ( ) (HAC) HAC HAC HAC 1 17 5 1-109- 16 260

2001 2003 2005 2006 2007 2008

2001 2003 2005 2006 2007 2008 60 etc. http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8% AAN 65

一般社団法人 日本感染症学会 第89回総会資料

Longitudinal surveillance of Haemophilus influenzae isolates from pediatric patients with meningitis throughout Japan, 2000 2011 Journal of Infection and Chemotherapy Vol.19No.1 p34-41kimiko Ubukata Long-term

_02三浦.indd

36, 7-11, 2016 IPD PCV 5 3 80% 1 invasive pneumococcal disease ; IPD 2010 7 PCV7 2013 13 PCV13 IPD IPD 2,3 2015 1 2015 12 5 1 IPD 2015 1 12 IPD 5 IPD 1 4 2 5 http://pneumocatch.jp/ 5 Statens Serum Institut

NGO HIV HIV 8, ,378 1,078 1,331 2,409 9,749 2,038 11,787 2, , ,118 2,344 1,352 3, , ,

HIV HIV HIV HIV HIV NGO HIV HIV HIV HIV HIV HIV HIV HIV HIV 41 NGO 1 2010 3 28 HIV HIV 8,671 707 9,378 1,078 1,331 2,409 9,749 2,038 11,787 2,004 574 2,578 340 778 1,118 2,344 1,352 3,696 1 5,721 4 5,725

SBP hospitalist network.key

1 Treatment and Prophylaxis of Spontaneous Bacterial Peritonitis (1); (2), (3). (1) (2) (3) :, :, 2 Clinical Question 1 72...,.,,.,... 3. CT..,. 4? SBP? SBP. 5 Clinical Question SBP? SBP,? 6 SBP (Spontaneous

八戸大学紀要_45_表1pdf

1 2 189 43 35 19 7 2 2000 60 2007 Key words : ICD - 10 I. 1. 1 1 2 2 4 4 1 2 2. 105 45 II. 1. 2011 MMA Mixed Martial Arts : 2. 1 1 189 2 ICD - 10 2.0 3 2000 2007 CDC Centers for Disease Control and Preven-

1996 10 http://www1.mhlw.go.jp/shingi/1217-1.html Healthy People 2000 Final Review Actual Causes of Death in the United States, 2000 OECD OECDHealth Report 2005 1990 1998 11 46 6 25 2,060 400 1999

2.2 (1967) (1997,2003) 2.2 ( ) 11

( ) 2.1 10 2.2 (1967) (1997,2003) 2.2 ( ) 11 12 ( ) 90150 (684) (887) (1099) (1361) (1605) (1707) (1854) 21(1946) 8 2.3 (1854) 13 (1997) (1854.12.23) (M8.4) (24 ) (M8.4) 70,000 3000 ( ) 7 2 3 3 (,1997)

5

Key words: pure red cell anemia, allogeneic bone marrow transplantation.

Complete Recovery of Hemopoiesis Following Bone Marrow Transplantation in a Patient with Unresponsive Congenital Pure Red Cell Anemia Masami SHIMADA, Hideo MUGISHIMA, Mitsuhiko HARA, Masahiro MISAWA, Hideo

Table 1 Survival rates of infected mice given antibiotic doses producing peak serum a) S. aurcus Smith Challenge dose :7 ~10 (5% mucin) CFU/mouse. LD50: 1 ~103 (5% mucin) CFU/mouse. Table 2 Survival rates

200mg 2005 3 876179 2002 3 3 200mg VFEND for Intravenous Use (1) (2) [4.1 ] (3) [4.2 ] (1) [1] (2) (3) [1] 3

Synagis RS RSRespiratory Syncytial Virus RSBPD CHDRS RS RS BPD CHD 50mg100mg RS20138 RS Respiratory Syncytial Virus RS

RS Synagis RS RSRespiratory Syncytial Virus RSBPD CHDRS RS RS1998 7020021BPD 200510CHD 50mg100mg2012 812 RS20138 RS Respiratory Syncytial Virus RS 28 12 29 35 6 6BPD24 24CHD 24 24 28 2935 RS 12 6 RS BPD

Copyright 2001, 1999, 1997, 1995, 1993, 1991, 1990 by The McGraw-Hill Companies, Inc. All rights reserved. Printed in the United States of America. Except as permitted under the United States Copyright

Ⅱ Ⅲ Ⅳ Assertive community treatment - Issues from scientific and clinical literature with implications for practice The Impact of Supported Employment and Working on Clinical and

et al No To Shinkei Clin Neurol Neurology et al J Neurosurg et al Arch Neurol et al Angiology

37 Recommendations for the Management of Moyamoya Disease A Statement from Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) Research on intractable diseases of the

本文／依頼２＿和気先生（４Ｃ）　☆

Ann Jpn Prosthodont Soc 4 : 256-266, 2012 Historical Changes of Psychosomatic Therapy for Patients with Temporomandibular Disorders Hiroyuki Wake, PhD, DDS a, and Osamu Komiyama, PhD, DDS b 256 257 258

1) Steinbrocker, O.: The shoulder-hand syndrome in reflex dystrophy of the upper ex- tremity, Ann. Intern. Med., 29: 22, 1948. 5) Greenfield, A. D. M., Whitney, R. J. and Mowbray, J. F.: Methods for the

No.10

Unio Internationalis Contra Cancrum International Union Against Cancer UICC UICC 2009.4 1 UICC News Letter No.10 2 2009.4 3 UICC News Letter No.10 4 2009.4 5 UICC News Letter No.10 6 The fight against

食道がん化学放射線療法後のsalvage手術

2006 2 17 52 Daly JM, et al. J Am Coll Surg 2000;190:562-573 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:562-573

小児感染免疫第23巻第1号

Vol. 23No. 163 42 HPV HPV 1113 HPV 42 HPV HPV HPV 1 1 510 1020 HPV 1020 510 HIV 0.1 0.005 HIV 2030 HIV 0.2 510 HPV 1020 15 HIV 2030 HIV HIV 0.2 0.1 Takeyuki Sato 2608677 181 64 2011 2 1 1518 6,000 513

ひまわり36号P0_3校

The woods in Tama-Zenshoen as the National Sanatorium for Hansen's disease Takayuki SHIBATA

The woods in Tama-Zenshoen as the National Sanatorium for Hansen's disease Takayuki SHIBATA 1979 1909 28 10 1154 1907 1931 1953 21 1996 2003 11 39 44-1 2006 1909 10 1922 67281 23 15418 31 31315 37 31133

Understanding Stem Cell Transplant 2007

Understanding Stem Cell Transplant IMF International Myeloma Foundation 12650 Riverside Drive, Suite 206 North Hollywood, CA 91607 USA Telephone: 800-452-CURE (2873) (USA & Canada) 818-487-7455 Fax: 818-487-7454

胆石症

ESWL ESWL LC QALE LC RCT cm 76 ESWL ESWL - - mm US X CT HU ESWL - ESWL ESWL UDCA, ESWL, UDCA, ESWL 77 Mirizzi - ; 90 : - Nicholl JP, Brazier JE, Milner PC, et al. Randomised controlled trial of cost-effectiveness

70% ADCA 28% SCA6 30% MJD 30% DRPLA 13% 20% SCA1 4% SCA2 3% RCA 2% 537 25 T2 C3 C6) LCL MRI OB ph3 ph9 60/40/20mg/ 1000mg/ 3 500mg/ 6 1000mg/ 3 6/ 2 1 2 3 50 25 0 75 100 % 100 33 67 75 80

untitled

2008/04/27 1. 1 2 staticdynamics etc 3 Hedberg A, Carlberg EB, Forssberg H, Hadders-Algra M. Development of postural adjustments in sitting position during the first half year of life. Dev Med Child Neurol.

1) University Group Diabetes Program: A study of hypoglycemic agents on vascular complica- in patients with adult-onset tions diabetes. I. Design, methods and baseline results. Diabetes 19 (suppl. 2):

日本目録規則1987年版改訂2版第2章図書改定案

2.0.1 2.0.2 2.0.3 2.0.4 2.0.5 2.0.6 2.1.1 2.1.2 2.1.3 2.1.4 2.1.5 2.2.1 2.2.2 2.2.3 2.2.4 2.4.1 2.4.2 2.4.3 2.4.4 2.5.1 2.5.2 2.5.3 2.5.4 2.6.1 2.6.2 2.6.3 2.6.4 2.6.5 ISSN 2.6.6 2.6.7 2.7.1 2.7.2 2.7.3

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio

7-14 2010 1 1 1 2 1 1 1 2 Fontaine II ASO61 3 API ASO ASO ASO API API KKKKKKKKKK ASO Fontaine II API Received April 14, 2009; Accepted July 16, 2009 I arteriosclerosis obliterans: ASO ASO 50 70 1,2 Fontaine

結核の接触者健康診断の手引き（改訂第４版）

2022 22 4 990-0031 FAX 023-641-7486 19 4 2007 4 18 19 7 2007 7 19 6 7 0308001 6 15 20 6 2008 6 1) 20 9 7 0907001 10 1 2) 4 3) QFT 4) QFT QFT 22 6 2010 6 QFT QFT QFT-3G QFT QFT window period QFT QFT X 19

日本でエイズが増え続ける原因は何か

2005 12 22 12022050 1 2 HIV AIDS 3 3.1 HIV 3.2 3.3 1 2 3.4 1 2 3 3.5 3.6 3.7 4 4.1 HIV AIDS 4.2 4.3 4.4 4.5 4.6 5 5.1 5.2 6 URL 1 1981 5 24 5 4,000 UNAIDS 2005 490 AIDS 310 110 140 2 1.5 HIV 2004 HIV 6,527

001.indd

OECD45.1 OECD 13.3 1 50 1 1988 2008 2 3 2 4 6 1 2 3 70 4 1 2011 2KBS 150kg7,000 500 1 20 1.5 870 2080 20102009 65 48.9 58.3 1 2 1 2008 58.4 4.3 46.3 272.2 2 46.527.2 2.0 28.216.4 1.2 58.4 100.0 14.8 25.4

™·”õ/sec3_p63_84/fiü“eflÅ

Section3 64 1 65 Section 3 1 2 3 4 5 6 7 8 9 10 11 12 13 14 1 Babara E. Ainsworth et al. Med. Sci. Sports. Exevc.1993 66 67 Section 3 1 10 9 8 1 2 3 4 7 6 5 6 7 5 1 2 3 4 68 69 Section 3 2 70 Section 3

MM0506-Ariyoshi.ind

51 2005133 Six years of experiences at the U.K. MRC Laboratories, The Gambia, in West Africa Koya ARIYOSHI 130 1965 1992 Jonathan Weber Medical Research Council MRC Laboratories, The Gambia HIV Virologist/Immunologist

Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo

Kekkaku Vol. 79, No. 1: 17-24, 2004 17 (Received 21 Aug. 2003/Accepted 18 Nov. 2003) Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly

manu_fi„‰ž½À°_‚““⁄ÊßÝÌ_‘oŠÍ

第２章　旧軍飛行場用地問題の歴史的な背景とその後の経過　　

23 24 25 26 27 28 1 29 2 3 30 4 31 5 6 32 33 34 7 8 35 36 37 38 39 40 41 42 9 10 43 44 11 12 45 13 14 46 15 FECFar East Commnad 16 Directive for United States Civil Administration of the Ryukyu Islands.

The clinical characteristics of Mycoplasma pneumoniae pneumonia in children younger than 6 years old Nobue Takeda1,2),Tomomichi Kurosaki1),Naruhiko Ishiwada2),Yoichi Kohno2) 1)Department of Pediatrics,Chiba

Single slice helical CT CT 1 2005 1 4 1. CT Anti-Lung Cancer Association: ALCA 1-5) 1993 9 10 ALCA (Nawa 6) ) single slice helical CT 10mm CT 2. 1 (http://www.thoracic-ctscreening.org/jpn/index.html )

1965( 40) * 1969( 44) 1996( 8) 5 * 1995( 7) 10 10 1997( 9) 10 1996( 8) 12 5 2000( 12) 12 2002 14 3

1 20 1948( 23) 12 10 3 ( )* 1993( 5) 1994( 6) 1995( 7) 2004( 16) 10 10 10 * 1965( 40) * 1969( 44) 1996( 8) 5 * 1995( 7) 10 10 1997( 9) 10 1996( 8) 12 5 2000( 12) 12 2002 14 3 * 2003 15 10 2 HIV* * 1997(

164 SDD & SOD SDD E100 mg 80 mg B500 mg 2 E 2 B 48 /59 81 SDD SOD 10 /63 16 RCT RCT 1992 Gastinne 15 ICU 445 SDD E100 mg 80 mg B 10

163 特 集 SDD & SOD SDD(Selective digestive decontamination),sod(selective oropharynx decontamination), 腸内細菌叢, 耐性菌 Ⅰ はじめに SDD Selective digestive decontamination SOD Selective oropharynx decontamination

13 5 1 217.49 19.5 19.3 1 (10) (11) (4) 2 () 1 2 3 1 () 32 1 46 6 () 4 () (17) (74) 5 6 61 ー 7 () ( ) 8 9 10 11 12 27 31 5 13 829-1844 620-2654 669-6054 646-3054 681-6054 840-6054 856-6164 829-6124 844-7164

A

ASD PTSD K6/K10 IES-R PTSD B.Raphael J.S.Tyhust 1225 75 1225 A. 3 B. C. 90 A. B. C. D. PTSD PTSD PTSD ASD PTSD ASD 4 2 4 PTSD / ASD 4 PTSD 20 80 1 Cf. Horowitz 7 PTSD PTSD PTSD 1317 PTSD ASD PTSD 1 1.5~5%

表1.eps

Vol.1 C ontents 1 2 cell-free EMBO J Proc. Natl. Acad. Sci. USA NatureEMBO J 3 RNA NatureEMBO J Nature EMBO J 4 5 HCV HCV HCV HCV RNA HCV in situ 6 7 8 Nat Struct Mol Biol J Biol Chem Nat Commun J Virol

慢性膵炎

- - 121 , g CCK g g - kgkcal kgkcal - g,,, - G.I.Res ; 10 : - ; 13 : - ; 22 : - Meier RF, Beglinger C. Nutrition in pancreatic diseases. Best Pract Res Clin Gastroenterol ; 20 : - Pfutzer RH, Schneider

1_2.eps

第32回 日本頭頸部癌学会ランチョンセミナー6 Pre-Meeting Abstract FDG-PET の頭頸部癌における臨床的有用性 司会 長 放射線治療センター長 講演 1 耳鼻咽喉科 部長 講演 2 PETセンター長 岡村 光英 先生 日時 2008年6月13日 金 12:00 13:00 会場 ハイアットリージェンシー東京 共催 第32回 日本頭頸部癌学会 日本メジフィジックス株式会社 136-0075

MI( MI() 100% 100% 75% 75% 33% 75% 60% 40% 25% 60% 1 2 3 4 5 6 7 8 9 () 12 () () () !! 1. 2. 3. 1. 2. () () () 3-5% ex. ex. 11 ex. () ex. ex. : ex. : (insula) () () ( 2009 ) () ( ) YES! ()

終末期癌患者に対する 輸液治療の是非

3 A B NSAID D Case stories A B NSAID D Case stories A. IASP Task Force on Taxonomy WHO Collaborating Center for Palliative Cancer Care : Looking forward to cancer pain relief for all. CBC Oxford, Oxford,